Correlation Between Century Therapeutics and Immutep

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Immutep Ltd ADR, you can compare the effects of market volatilities on Century Therapeutics and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Immutep.

Diversification Opportunities for Century Therapeutics and Immutep

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Century and Immutep is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Immutep go up and down completely randomly.

Pair Corralation between Century Therapeutics and Immutep

Given the investment horizon of 90 days Century Therapeutics is expected to generate 1.39 times more return on investment than Immutep. However, Century Therapeutics is 1.39 times more volatile than Immutep Ltd ADR. It trades about 0.35 of its potential returns per unit of risk. Immutep Ltd ADR is currently generating about 0.14 per unit of risk. If you would invest  115.00  in Century Therapeutics on September 1, 2024 and sell it today you would earn a total of  57.00  from holding Century Therapeutics or generate 49.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  Immutep Ltd ADR

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Century Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Century Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Immutep Ltd ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Century Therapeutics and Immutep Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and Immutep

The main advantage of trading using opposite Century Therapeutics and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.
The idea behind Century Therapeutics and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine